GID-MT568 Magtrace and Sentimag for locating sentinel lymph nodes: draft guidance
We are listening to your views on this Medical technologies guidance. Comments close 16 June 2022.
Search results
6 results
-
-
Tucatinib with trastuzumab and capecitabine for treating HER2-positive unresectable locally advanced or metastatic breast cancer after 2 or more anti-HER2 therapies [ID3828]: appraisal consultation
We are listening to your views on this Technology appraisal guidance. Comments close 16 November 2021.
-
Zanubrutinib for treating Waldenström's macroglobulinaemia [ID1427]: draft guidance
We are listening to your views on this Technology appraisal guidance. Comments close 26 May 2022.
-
Finerenone for treating chronic kidney disease in people with type 2 diabetes [ID3773]: draft guidance
We are listening to your views on this Technology appraisal guidance. Comments close 6 June 2022.
-
Lumasiran for treating primary hyperoxaluria type 1 [ID3765]: draft guidance
We are listening to your views on this Technology appraisal guidance. Comments close 13 June 2022.
-
Avacopan for treating severe active granulomatosis with polyangiitis or microscopic polyangiitis [ID1581]: draft guidance
We are listening to your views on this Technology appraisal guidance. Comments close 17 June 2022.